Vivek Kopparthi’s NeoLight helps infants suffering from jaundice
Kopparthi, 25, is co-founder and chief executive officer of NeoLight, a medical device company that develops phototherapy technology to cure jaundice in babies. The company has developed two portable products: NeoLight SkyLife, which runs on electricity, for the U.S. market and the NeoLight SunLife for developing countries, where electricity may not be readily available. The latter unit runs on solar power, battery or electricity. Typical jaundice equipment, which runs on electricity, is a 5-foot-tall unit that isn’t readily portable.
###
NeoLight is a medical device company that develops empathy driven, best-in-class technologies for treating preventable conditions in the newborn care market. Empathy driven solutions are a framework that has the doctor-nurse-mother-infant ecosystem at the center. It fosters the emotional connection that happens, thereby providing not just treatment but also providing care. Driving neonatal care beyond the traditional hospital setting, NeoLight is also creating a robust home market to treat neonatal conditions in the home. To learn more, visit www.theneolight.com and follow us on Twitter and LinkedIn.
